Related Experiment Video
Updated: Mar 26, 2026
08:34
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
10.8K
High Mobility Group A2 protects cancer cells against telomere dysfunction
Suchitra Natarajan1, Farhana Begum1, Jeonga Gim1
1Department of Human Anatomy and Cell Science, College of Medicine, University of Manitoba, Winnipeg, Canada.
Oncotarget
|January 23, 2016
Summary
High Mobility Group AT-hook protein 2 (HMGA2) stabilizes telomeres in cancer cells by interacting with TRF2. Loss of HMGA2 leads to telomere instability and DNA damage signaling, highlighting HMGA2 as a therapeutic target.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- High Mobility Group AT-hook protein 2 (HMGA2) is a non-histone chromatin protein crucial for DNA repair and protection.
- HMGA2's role in maintaining genomic stability is recognized in both embryonic stem cells and cancer cells.
Purpose of the Study:
- To investigate the localization and function of HMGA2 at mammalian telomeres.
- To elucidate the novel interaction between HMGA2 and the shelterin complex component TRF2.
- To determine the impact of HMGA2-TRF2 interaction on telomere stability and DNA damage response in cancer cells.
Main Methods:
- Chromatin immunoprecipitation (ChIP) assays to assess TRF2 binding to telomeres.
- Analysis of HMGA2 interaction domains with TRF2, including specific molecular regions and TRF2 structural components.
- Assessment of telomere instability markers such as telomere dysfunction-induced foci (TIF), aggregation, anaphase bridges, and micronuclei.
- Investigation of the ATM-CHK2-CDC25C DNA damage signaling pathway and its regulation by HMGA2 and TRF2 phosphorylation.
Main Results:
- HMGA2 was found to localize to mammalian telomeres and enhance telomere stability in cancer cells.
- A novel interaction between HMGA2 (specifically its ATI-L1-ATII region) and TRF2 (involving its homodimerization and hinge regions) was identified.
- HMGA2 retained TRF2 at telomeres, reduced telomere dysfunction under stress, and prevented ATM-dependent pTRF2T188 phosphorylation.
- Silencing HMGA2 decreased TRF2 telomere binding, increased telomere instability, and promoted TIF formation, leading to increased aggregation, anaphase bridges, and micronuclei.
- HMGA2 attenuated the telomere-specific ATM-CHK2-CDC25C DNA damage signaling axis.
Conclusions:
- HMGA2 plays a critical role in telomere protection and stability in cancer cells through its interaction with TRF2.
- This interaction prevents telomere dysfunction and DNA damage signaling, contributing to cancer cell survival.
- HMGA2 represents a novel therapeutic target for destabilizing telomeres in HMGA2-positive cancer cells.
More Related Videos
Related Concept Videos
02:36DNA Damage can Stall the Cell Cycle
10.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
02:36DNA Damage Can Stall the Cell Cycle
3.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
02:15Replicative Cell Senescence
4.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:53Adaptive Mechanisms in Cancer Cells
4.2K
4.2K